U.S. markets close in 5 minutes

22nd Century Group, Inc. (XXII)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
4.0450+0.1350 (+3.45%)
As of 3:55PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Williams %R

Williams %R

Previous Close3.9100
Open3.8800
Bid4.0700 x 1000
Ask4.0800 x 1400
Day's Range3.8200 - 4.1800
52 Week Range0.5500 - 6.0700
Volume2,117,758
Avg. Volume4,674,045
Market Cap616.636M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • 22nd Century Group (XXII) Q1 2021 Earnings Call Transcript
    Motley Fool

    22nd Century Group (XXII) Q1 2021 Earnings Call Transcript

    At this time, I would like to turn the call over to Mei Kuo, director of communications and investor relations. Joining me today are; Jim Mish, our chief executive officer; Mike Zercher, our president and chief operating officer; and John Franzino, our chief financial officer.

  • 22nd Century Group (XXII) Reports Q1 Loss, Misses Revenue Estimates
    Zacks

    22nd Century Group (XXII) Reports Q1 Loss, Misses Revenue Estimates

    22nd Century (XXII) delivered earnings and revenue surprises of 0.00% and -6.12%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

  • An Upcoming FDA Decision on Nicotine Could Send This Stock Soaring
    Motley Fool

    An Upcoming FDA Decision on Nicotine Could Send This Stock Soaring

    With so much hype around cannabis legalization at the state, and potentially federal, level, it can be easy to lose track of the debate involving cigarette smoking and nicotine addiction. Now comes word that the Biden administration is considering a proposal from the U.S. Food and Drug Administration (FDA) to reduce nicotine levels in all cigarettes sold in the U.S. to minimally or non-addictive levels. For 22nd Century, in particular, this could be the moonshot it's been waiting for.